Burgopak’s Pharmaceutical Packaging Achieves F=1 Child Resistant Rating

(PRESS RELEASE) Burgopak has successfully achieved the U.S. Consumer Product and Safety Commission’s F=1 standard for child-resistant effectiveness and the senior-friendly criteria. Named “Best Compliance Package” at the 2008 Pharmapack in Paris, Burgopak continues to advance the technology of pharmaceutical compliance packaging with its compelling designs.

Burgopak’s packaging offers single- and double-blister packs sliding out to reveal both the blister and the attached patient information leaflet.

Datamonitor reported in 2004 that four out of every ten patients in the United States fail to take their medication as prescribed. The pharmaceutical packaging industry has been tasked with finding the right balance between usage, senior-friendly accessibility, and child resistance. Burgopak’s Pharmaceutical Series packaging presents an impressive solution with single- and double-blister packs sliding out to reveal both the blister and the attached patient information leaflet.

The latest addition to Burgopak’s Pharmaceutical Series achieved the F=1 standard with impressive results—child-resistant effectiveness at 98% and senior adult use effectiveness at a pass rate of 95%. Patient compliance is one of the most discussed topics in the pharmaceutical industry today and represents a challenge for healthcare providers and manufacturers alike. Burgopak’s sliding packages ensures that all compliance and safety information remains conveniently attached to the medication at all times, while not making the pack cumbersome or awkward to use.

Burgopak’s recent partnership with RxPak, a subsidiary of McKesson Corporation, will bring its pioneering pharmaceutical packaging style to the American market in 2010. Fully automated production on innovative Bosch Sigpack machinery makes the Burgopak design a cost-effective, reliable, and entirely customizable unit dose package. For more, visit www.BurgopakHealthcare.com.